Alcoholic Hepatitis Histological Scoring System
The Alcoholic Hepatitis Histological Scoring System predicts 90‑day mortality using fibrosis, neutrophil infiltration, bilirubinostasis, and megamitochondria on biopsy 1.
사용 적응증
Used when liver biopsy is performed for suspected alcoholic hepatitis with diagnostic uncertainty or for clinical trial enrollment, as biopsy is not routinely required. The score’s utility is prognostic only, estimating 90‑day mortality risk based on four histologic features (fibrosis, neutrophils, bilirubinostasis, megamitochondria) 1 [Level I evidence]. Validation shows risk stratification but no superiority to clinical scores in severe AH 2 [Level II evidence].
통찰 및 주의사항
Stronger prognostic value comes from fibrosis, neutrophil infiltration, bilirubinostasis type, and megamitochondria; these define low, moderate, and high 90‑day mortality risk (3%, 19%, 51%) 1 [Level I evidence]. However, accuracy is modest, interobserver variability is substantial, and severe AH shows limited short‑term prognostic discrimination 2 [Level II evidence]. Requires biopsy within 48 h and is less practical than clinical scores.